Hillsdale Investment Management’s Kite Pharma, Inc. KITE Stock Holding History

Hillsdale Investment Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-500	Closed	-$90K	–	558
2017 Q3	$90K	Buy	+500	New	+$69.7K	0.02%	305

Hillsdale Investment Management's KITE Position: Q4 2017 in Review

Hillsdale Investment Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 500 shares — an estimated $90K sold.

Hillsdale Investment Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $90K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Hillsdale Investment Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Hillsdale Investment Management sold 500 Kite Pharma, Inc. shares in Q4 2017, an estimated $90K.
Hillsdale Investment Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
Hillsdale Investment Management's Kite Pharma, Inc. position peaked at $90K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Hillsdale Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.